Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Photodynamic therapy in the anti-VEGF era.

× No keyword cloud information.

14 in total

1. Recurrence of choroidal neovascularisation after photodynamic therapy in patients with age-related macular degeneration.

Authors: Michael J Potter; Shelagh M Szabo
Journal: Br J Ophthalmol Date: 2007-01-17 Impact factor: 4.638

Review 2. VEGF as a therapeutic target in cancer.

Authors: Napoleone Ferrara
Journal: Oncology Date: 2005-11-21 Impact factor: 2.935

Review 3. Multiple comparison procedures updated.

Authors: J Ludbrook
Journal: Clin Exp Pharmacol Physiol Date: 1998-12 Impact factor: 2.557

4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors:
Journal: Arch Ophthalmol Date: 1999-10

Review 5. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.

Authors:
Journal: Retina Date: 2005 Feb-Mar Impact factor: 4.256

6. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

Authors: Mohammad Azab; David S Boyer; Neil M Bressler; Susan B Bressler; Ilona Cihelkova; Young Hao; Ilkka Immonen; Jennifer I Lim; Ugo Menchini; Joel Naor; Michael J Potter; Al Reaves; Philip J Rosenfeld; Jason S Slakter; Peter Soucek; H Andrew Strong; Andrea Wenkstern; Xiang Yao Su; Yit C Yang
Journal: Arch Ophthalmol Date: 2005-04

7. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

Authors: Richard F Spaide; Ketan Laud; Howard F Fine; James M Klancnik; Catherine B Meyerle; Lawrence A Yannuzzi; John Sorenson; Jason Slakter; Yale L Fisher; Michael J Cooney
Journal: Retina Date: 2006-04 Impact factor: 4.256

8. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors:
Journal: Am J Ophthalmol Date: 2001-05 Impact factor: 5.258

9. Photosensitizers in photodynamic therapy.

Authors: J G Levy
Journal: Semin Oncol Date: 1994-12 Impact factor: 4.929

10. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.

Authors: Jeffrey S Heier; Andrew N Antoszyk; Peter Reed Pavan; Steven R Leff; Philip J Rosenfeld; Thomas A Ciulla; Richard F Dreyer; Ronald C Gentile; Judy P Sy; Gary Hantsbarger; Naveed Shams
Journal: Ophthalmology Date: 2006-02-14 Impact factor: 12.079

2 in total

1. Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex.

Authors: Ilias Georgalas; Alexandros A Rouvas; Dimitrios A Karagiannis; Athanasios I Kotsolis; Ioannis D Ladas
Journal: Clin Ophthalmol Date: 2009-06-02

2. Angioid streaks, clinical course, complications, and current therapeutic management.

Authors: Ilias Georgalas; Dimitris Papaconstantinou; Chrysanthi Koutsandrea; George Kalantzis; Dimitris Karagiannis; Gerasimos Georgopoulos; Ioannis Ladas
Journal: Ther Clin Risk Manag Date: 2009-03-26 Impact factor: 2.423

2 in total